OverviewSuggest Edit

PharmaEssentia is a biotech company focused on the areas of hematology, oncology, dermatology, and infectious diseases. Its lead compound is ropeginterferon alfa-2b, an interferon for myeloproliferative neoplasms and hepatitis. The company also develops treatments for gastric, gastro-esophageal, esophageal, and breast cancer, as well as psoriasis.
TypePublic
Founded2003
HQTW
Websitepharmaessentia.com
Employee Ratings4.8

Latest Updates

Employees (est.) (Jun 2019)190
Share Price (Jun 2021)NT$91.5
Cybersecurity ratingBMore

Key People/Management at PharmaEssentia

Kochung Lin

Kochung Lin

Founder and CEO
Albert Qin

Albert Qin

Chief Medical Officer
Craig Zimmerman

Craig Zimmerman

Vice President of US Operations
Yi-Wen Huang

Yi-Wen Huang

Senior Director, Medical Research & Clinical Operation
Chaosheng Cheng

Chaosheng Cheng

Senior Director of Biologics Manufacturing
Show more

PharmaEssentia Office Locations

PharmaEssentia has offices in Burlington and Shinjuku City
Shinjuku City, JP
2-chōme-5-12 Shinjuku
Burlington, MA, US
35 Corporate Dr #325
Show all (5)

PharmaEssentia Financials and Metrics

PharmaEssentia Revenue

Market capitalization (18-Jun-2021)

23.8b

Closing stock price (18-Jun-2021)

91.5
PharmaEssentia's current market capitalization is NT$23.8 b.
Show all financial metrics

PharmaEssentia Cybersecurity Score

Cybersecurity ratingPremium dataset

B

80/100

SecurityScorecard logo

PharmaEssentia Online and Social Media Presence

Embed Graph

PharmaEssentia News and Updates

Axis Therapeutics Announces Research Collaboration with PharmaEssentia for Development of TCR-T Cell Therapy in Taiwan

BUFFALO, N.Y., Oct. 12, 2020 (GLOBE NEWSWIRE) -- Axis Therapeutics Limited, a joint venture between Athenex, Inc. (NASDAQ: ATNX) and Xiangxue Life Sciences Limited (“XLifeSc”), focused on the research, development, and commercialization of T cell immunotherapy, today announced that it has entered …

PharmaEssentia Frequently Asked Questions

  • When was PharmaEssentia founded?

    PharmaEssentia was founded in 2003.

  • Who are PharmaEssentia key executives?

    PharmaEssentia's key executives are Kochung Lin, Albert Qin and Craig Zimmerman.

  • How many employees does PharmaEssentia have?

    PharmaEssentia has 190 employees.

  • Who are PharmaEssentia competitors?

    Competitors of PharmaEssentia include Takeda Oncology, Black Diamond Therapeutics and PLIVA.

  • Where are PharmaEssentia offices?

    PharmaEssentia has offices in Burlington and Shinjuku City.

  • How many offices does PharmaEssentia have?

    PharmaEssentia has 5 offices.